Design Therapeutics Inc
DSGN3.960USD
+0.140+3.66%
收盘 08/04, 16:00（美东）报价延迟15分钟
3.960USD+3.960盘后交易 (美东)
224.80M总市值
亏损市盈率 TTM
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q2
FY2020Q1
营业总收入
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--31.00K
--142.00K
营业收入
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--31.00K
--142.00K
营业费用
41.79%20.42M
10.40%16.69M
-13.69%16.25M
-33.43%15.04M
-33.49%14.40M
-22.02%15.12M
-1.93%18.82M
44.48%22.60M
61.94%21.65M
74.28%19.39M
69.29%19.19M
103.45%15.64M
135.39%13.37M
--11.13M
--11.34M
414.52%7.69M
642.48%5.68M
--1.49M
--765.00K
研发费用
56.89%15.38M
10.40%12.16M
-10.42%11.88M
-38.37%10.52M
-37.69%9.80M
-22.75%11.01M
-7.32%13.26M
51.08%17.06M
79.59%15.73M
94.29%14.26M
67.51%14.30M
124.69%11.29M
126.04%8.76M
--7.34M
--8.54M
373.80%5.03M
927.85%3.88M
--1.06M
--377.00K
折旧摊销及损耗
11.19%159.00K
7.97%149.00K
11.68%153.00K
13.53%151.00K
10.85%143.00K
11.29%138.00K
26.85%137.00K
44.57%133.00K
57.32%129.00K
51.22%124.00K
248.39%108.00K
666.67%92.00K
1950.00%82.00K
--82.00K
--31.00K
--12.00K
--4.00K
----
----
营业利润
-41.79%-20.42M
-10.40%-16.69M
13.69%-16.25M
33.43%-15.04M
33.49%-14.40M
22.02%-15.12M
1.93%-18.82M
-44.48%-22.60M
-61.94%-21.65M
-74.28%-19.39M
-69.29%-19.19M
-103.45%-15.64M
-135.39%-13.37M
---11.13M
---11.34M
-425.43%-7.69M
-811.72%-5.68M
---1.46M
---623.00K
净非营业利息收入（费用）
利息收入
--2.70M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
其他非经营性收入（费用）
----
-7.20%3.04M
5.74%3.21M
22.23%3.25M
39.80%3.29M
59.80%3.28M
103.83%3.03M
315.47%2.66M
2144.76%2.36M
3209.68%2.05M
7731.58%1.49M
1154.90%640.00K
-36.75%105.00K
--62.00K
--19.00K
142.86%51.00K
515.00%166.00K
--21.00K
---40.00K
税前利润
-59.52%-17.71M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-56.71%-17.34M
-56.42%-17.70M
-96.42%-15.00M
-140.57%-13.27M
---11.06M
---11.32M
-429.54%-7.64M
-731.67%-5.51M
---1.44M
---663.00K
除税后利润
-59.52%-17.71M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-56.71%-17.34M
-56.42%-17.70M
-96.42%-15.00M
-140.57%-13.27M
---11.06M
---11.32M
-429.54%-7.64M
-731.67%-5.51M
---1.44M
---663.00K
持续经营利润
-59.52%-17.71M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-56.71%-17.34M
-56.42%-17.70M
-96.42%-15.00M
-140.57%-13.27M
---11.06M
---11.32M
-429.54%-7.64M
-731.67%-5.51M
---1.44M
---663.00K
归属于母公司的净利润
-59.52%-17.71M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-56.71%-17.34M
-56.42%-17.70M
-96.42%-15.00M
-140.57%-13.27M
---11.06M
---11.32M
-429.54%-7.64M
-731.67%-5.51M
---1.44M
---663.00K
归属于普通股东的净利润
-59.52%-17.71M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-56.71%-17.34M
-56.42%-17.70M
-96.42%-15.00M
-140.57%-13.27M
---11.06M
---11.32M
-429.54%-7.64M
-731.67%-5.51M
---1.44M
---663.00K
基本每股收益
-58.77%-0.31
-14.07%-0.24
18.34%-0.23
41.48%-0.21
43.03%-0.20
31.98%-0.21
11.15%-0.28
-32.26%-0.36
-44.41%-0.35
-55.59%-0.31
-54.67%-0.32
-94.34%-0.27
23.59%-0.24
---0.20
---0.21
-146.10%-0.14
-1106.64%-0.31
---0.06
---0.03
稀释每股收益
-58.77%-0.31
-14.07%-0.24
18.34%-0.23
41.48%-0.21
43.03%-0.20
31.98%-0.21
11.15%-0.28
-32.26%-0.36
-44.41%-0.35
-55.59%-0.31
-54.67%-0.32
-94.34%-0.27
23.59%-0.24
---0.20
---0.21
-146.10%-0.14
-1106.64%-0.31
---0.06
---0.03
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
货币单位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
审计意见
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
